Cargando…

Effect of Paroxetine Combined with Probiotics in Patients with Type 2 Diabetes Mellitus Complicated with Gastrointestinal Dysfunction and Liver Cancer

BACKGROUND: To explore the effect of paroxetine combined with probiotics in patients with type 2 diabetes mellitus with gastrointestinal dysfunction and liver cancer and its effect on nutritional status. MATERIALS AND METHODS: 96 patients with type 2 diabetes mellitus combined with gastrointestinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yi, Yang, Xingxia, Wang, Yeju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516543/ https://www.ncbi.nlm.nih.gov/pubmed/34659410 http://dx.doi.org/10.1155/2021/4529915

Ejemplares similares

Cell-Based Screening Identifies Paroxetine as an Inhibitor of Diabetic Endothelial Dysfunction
por: Gerö, Domokos, et al.
Publicado: (2013)

Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine
por: Liang, Zihong, et al.
Publicado: (2021)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Gastrointestinal and Liver Complications in Patients with Diabetes Mellitus—A Review of the Literature
por: Mare, Ruxandra, et al.
Publicado: (2022)

Endothelial Dysfunction and Microvascular Complications in Type 1 Diabetes Mellitus
por: Jin, Seon Mi, et al.
Publicado: (2008)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Combination of valproate and paroxetine in mice exposed to picrotoxin
por: Kamal, Sahar M
Publicado: (2012)

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang, Ruiying, et al.
Publicado: (2015)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
por: Felício, João Soares, et al.
Publicado: (2018)

Thyroid dysfunction in patients with type 2 diabetes mellitus and its association with diabetic complications
por: Mehalingam, Vadivelan, et al.
Publicado: (2020)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Paroxetine overdose during pregnancy
por: Acar, Selin, et al.
Publicado: (2021)

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
por: Ai, Peng-Hui, et al.
Publicado: (2020)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
por: Du, Na, et al.
Publicado: (2015)

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
por: Aree, Thammarat
Publicado: (2022)

DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
por: Kanazawa, Ippei, et al.
Publicado: (2014)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Paroxetine—Overview of the Molecular Mechanisms of Action
por: Kowalska, Magdalena, et al.
Publicado: (2021)

Complications of the Type 2 Diabetes Mellitus
por: Farmaki, Paraskevi, et al.
Publicado: (2020)

Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
por: Li, Xiao-lin, et al.
Publicado: (2022)

Effects of probiotics on type II diabetes mellitus: a meta-analysis
por: Tao, Yun-Wen, et al.
Publicado: (2020)

Two cases of type 2 diabetes mellitus successfully treated with probiotics
por: Cardinali, Néstor, et al.
Publicado: (2020)

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019)

Hepatobiliary dysfunction in Type-2 diabetes mellitus
por: Manoria, Piyush, et al.
Publicado: (2017)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
por: Singh, Manjeet, et al.
Publicado: (2015)

Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter
por: Davis, Bruce A., et al.
Publicado: (2016)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Extra-Paramidal Side Effects Associated with Paroxetine
por: Nicholson, Simon D.
Publicado: (1992)

Successful Use of Risperidone, Trihexyphenidyl, and Paroxetine in Pregnancy
por: Goyal, Sandeep Kumar, et al.
Publicado: (2017)

Euprolactinemic Galactorrhea with Paroxetine: Exploring the Missing Link
por: Mishra, Shree, et al.
Publicado: (2019)

Musical Hallucinations Induced by Conventional Doses of Paroxetine
por: Muraosa, Haruka, et al.
Publicado: (2020)

The Antidepressant Paroxetine Reduces the Cardiac Sodium Current
por: Plijter, Ingmar S., et al.
Publicado: (2023)

Correction to: Effects of probiotics on type II diabetes mellitus: a meta-analysis
por: Tao, Yun-Wen, et al.
Publicado: (2020)

Gastrointestinal Microbiota and Type 1 Diabetes Mellitus: The State of Art
por: Durazzo, Marilena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9e165ntm7p127utliedb58nedt